Identification and validation of novel genes related to immune microenvironment in polycystic ovary syndrome
- PMID: 39470566
- PMCID: PMC11521087
- DOI: 10.1097/MD.0000000000040229
Identification and validation of novel genes related to immune microenvironment in polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is one of the most complicated chronic inflammatory diseases in women of reproductive age and is one of the primary factors responsible for infertility. There is substantial dispute relating to the pathophysiology of PCOS. Consequently, there is a critical need for further research to identify the factors underlying the pathophysiology of PCOS. Three transcriptome profiles of granulosa cells from patients with PCOS and normal controls were obtained from the gene expression integration database. We also obtained relevant microarrays of granulocytes prepared from PCOS patients and normal controls from the gene expression integration database. Then, we used the R package to perform correlations and identify differences between PCOS and normal controls with regard to immune infiltrating cells and functionality. Subsequently, intersecting genes were identified and risk models were constructed. Finally, the results were validated by enzyme linked immunosorbent assay and real-time PCR. We identified 8 genes related to cuproptosis (SLC31A1, PDHB, PDHA1, DLST, DLD, DLAT, DBT, and ATP7A) and 5 genes related to m7G (SNUPN, NUDT16, GEMIN5, DCPS, and EIF4E3) that were associated with immune infiltration. Furthermore, the expression levels of DLAT (P = .049) and NUDT16 (P = .024) differed significantly between the PCOS patients and normal controls, as revealed by multifactorial analysis. Both DLAT and NUDT16 were negatively correlated with immune cell expression and function and expression levels were significantly lower in the PCOS group. Finally, real-time PCR and enzyme linked immunosorbent assay demonstrated that the expression levels of DLAT and NUDT16 were significantly reduced in the granulosa cells of PCOS patients. In conclusion, our findings shed fresh light on the roles of immune infiltration, cuproptosis, and m7G alternations in PCOS. We also provide a reliable biomarker for the pathological classification of PCOS patients.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Different expression and localization of aquaporin 7 and aquaporin 9 in granulosa cells, oocytes, and embryos of patients with polycystic ovary syndrome and the negatively correlated relationship with insulin regulation.Fertil Steril. 2021 Feb;115(2):463-473. doi: 10.1016/j.fertnstert.2020.08.015. Fertil Steril. 2021. PMID: 33579525 Clinical Trial.
-
Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling.Sci Rep. 2015 Oct 13;5:14994. doi: 10.1038/srep14994. Sci Rep. 2015. PMID: 26459919 Free PMC article.
-
Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome.J Clin Endocrinol Metab. 2016 Sep;101(9):3459-68. doi: 10.1210/jc.2015-4275. Epub 2016 May 26. J Clin Endocrinol Metab. 2016. PMID: 27228368 Free PMC article.
-
Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome.Arch Gynecol Obstet. 2016 Jul;294(1):185-92. doi: 10.1007/s00404-016-4068-z. Epub 2016 Mar 18. Arch Gynecol Obstet. 2016. PMID: 26993517
-
Identification and validation of core genes associated with polycystic ovary syndrome and metabolic syndrome.Medicine (Baltimore). 2024 Oct 18;103(42):e40162. doi: 10.1097/MD.0000000000040162. Medicine (Baltimore). 2024. PMID: 39432623 Free PMC article.
References
-
- Li Y, Chen C, Ma Y, et al. . Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019;228:167–75. - PubMed
-
- Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36. - PubMed
-
- Rostamtabar M, Esmaeilzadeh S, Tourani M, et al. . Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol. 2021;236:824–38. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous